CN106692760A - 一种预防糖尿病的金花酒配方及其制备方法 - Google Patents
一种预防糖尿病的金花酒配方及其制备方法 Download PDFInfo
- Publication number
- CN106692760A CN106692760A CN201710036270.1A CN201710036270A CN106692760A CN 106692760 A CN106692760 A CN 106692760A CN 201710036270 A CN201710036270 A CN 201710036270A CN 106692760 A CN106692760 A CN 106692760A
- Authority
- CN
- China
- Prior art keywords
- parts
- golden flower
- tuber
- licorice
- rhizoma atractylodis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010012601 diabetes mellitus Diseases 0.000 title claims abstract description 55
- 238000002360 preparation method Methods 0.000 title claims abstract description 16
- 240000002853 Nelumbo nucifera Species 0.000 claims abstract description 35
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims abstract description 35
- 244000269722 Thea sinensis Species 0.000 claims abstract description 34
- 241000508269 Psidium Species 0.000 claims abstract description 29
- 241000866536 Odontotermes formosanus Species 0.000 claims abstract description 28
- 235000004347 Perilla Nutrition 0.000 claims abstract description 28
- 241000405414 Rehmannia Species 0.000 claims abstract description 27
- 235000011684 Sorghum saccharatum Nutrition 0.000 claims abstract description 22
- 235000021307 Triticum Nutrition 0.000 claims abstract description 22
- 240000006394 Sorghum bicolor Species 0.000 claims abstract description 18
- 230000002265 prevention Effects 0.000 claims abstract description 17
- 239000002994 raw material Substances 0.000 claims abstract description 17
- 240000002948 Ophiopogon intermedius Species 0.000 claims description 33
- 240000000249 Morus alba Species 0.000 claims description 31
- 235000008708 Morus alba Nutrition 0.000 claims description 31
- 241001571466 Potentilla discolor Species 0.000 claims description 28
- 241000202807 Glycyrrhiza Species 0.000 claims description 27
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 claims description 27
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims description 27
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 claims description 27
- 241000229722 Perilla <angiosperm> Species 0.000 claims description 27
- 229940010454 licorice Drugs 0.000 claims description 27
- 235000013616 tea Nutrition 0.000 claims description 26
- 238000000855 fermentation Methods 0.000 claims description 24
- 230000004151 fermentation Effects 0.000 claims description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 24
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims description 23
- 239000011449 brick Substances 0.000 claims description 23
- 241000209140 Triticum Species 0.000 claims description 21
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 21
- 239000003814 drug Substances 0.000 claims description 11
- 238000007654 immersion Methods 0.000 claims description 11
- 239000012530 fluid Substances 0.000 claims description 10
- 239000007788 liquid Substances 0.000 claims description 10
- 230000036541 health Effects 0.000 claims description 9
- 230000033228 biological regulation Effects 0.000 claims description 8
- 235000006468 Thea sinensis Nutrition 0.000 claims description 7
- 235000020279 black tea Nutrition 0.000 claims description 7
- 238000001816 cooling Methods 0.000 claims description 6
- 238000001035 drying Methods 0.000 claims description 6
- 238000004821 distillation Methods 0.000 claims description 5
- 239000012467 final product Substances 0.000 claims description 5
- 238000007789 sealing Methods 0.000 claims description 5
- 241000209072 Sorghum Species 0.000 claims description 4
- 241000256602 Isoptera Species 0.000 claims description 3
- 238000000746 purification Methods 0.000 claims 1
- 239000002689 soil Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 13
- 235000018142 Hedysarum alpinum var americanum Nutrition 0.000 abstract 1
- 240000006461 Hedysarum alpinum var. americanum Species 0.000 abstract 1
- 229930195210 Ophiopogon Natural products 0.000 abstract 1
- 244000248557 Ophiopogon japonicus Species 0.000 abstract 1
- 244000124853 Perilla frutescens Species 0.000 abstract 1
- 240000000103 Potentilla erecta Species 0.000 abstract 1
- 235000016551 Potentilla erecta Nutrition 0.000 abstract 1
- 244000184734 Pyrus japonica Species 0.000 abstract 1
- 244000098338 Triticum aestivum Species 0.000 abstract 1
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 22
- 239000008280 blood Substances 0.000 description 15
- 210000004369 blood Anatomy 0.000 description 15
- 102000004877 Insulin Human genes 0.000 description 12
- 108090001061 Insulin Proteins 0.000 description 12
- 229940125396 insulin Drugs 0.000 description 11
- 238000000034 method Methods 0.000 description 9
- 210000004027 cell Anatomy 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 210000000496 pancreas Anatomy 0.000 description 6
- 235000019197 fats Nutrition 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 230000002218 hypoglycaemic effect Effects 0.000 description 5
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 4
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 4
- 210000000227 basophil cell of anterior lobe of hypophysis Anatomy 0.000 description 4
- 239000011651 chromium Substances 0.000 description 4
- 229910052804 chromium Inorganic materials 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- LXBIFEVIBLOUGU-UHFFFAOYSA-N Deoxymannojirimycin Natural products OCC1NCC(O)C(O)C1O LXBIFEVIBLOUGU-UHFFFAOYSA-N 0.000 description 3
- 208000032843 Hemorrhage Diseases 0.000 description 3
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 3
- 230000023852 carbohydrate metabolic process Effects 0.000 description 3
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 208000001848 dysentery Diseases 0.000 description 3
- 210000004153 islets of langerhan Anatomy 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- KZJWDPNRJALLNS-VPUBHVLGSA-N (-)-beta-Sitosterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@@H](C(C)C)CC)C)CC4)CC3)CC=2)CC1 KZJWDPNRJALLNS-VPUBHVLGSA-N 0.000 description 2
- CSVWWLUMXNHWSU-UHFFFAOYSA-N (22E)-(24xi)-24-ethyl-5alpha-cholest-22-en-3beta-ol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(CC)C(C)C)C1(C)CC2 CSVWWLUMXNHWSU-UHFFFAOYSA-N 0.000 description 2
- KLEXDBGYSOIREE-UHFFFAOYSA-N 24xi-n-propylcholesterol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CCC)C(C)C)C1(C)CC2 KLEXDBGYSOIREE-UHFFFAOYSA-N 0.000 description 2
- LPZCCMIISIBREI-MTFRKTCUSA-N Citrostadienol Natural products CC=C(CC[C@@H](C)[C@H]1CC[C@H]2C3=CC[C@H]4[C@H](C)[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C LPZCCMIISIBREI-MTFRKTCUSA-N 0.000 description 2
- ARVGMISWLZPBCH-UHFFFAOYSA-N Dehydro-beta-sitosterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCC(CC)C(C)C)CCC33)C)C3=CC=C21 ARVGMISWLZPBCH-UHFFFAOYSA-N 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 229920002527 Glycogen Polymers 0.000 description 2
- 206010018473 Glycosuria Diseases 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- MJVXAPPOFPTTCA-UHFFFAOYSA-N beta-Sistosterol Natural products CCC(CCC(C)C1CCC2C3CC=C4C(C)C(O)CCC4(C)C3CCC12C)C(C)C MJVXAPPOFPTTCA-UHFFFAOYSA-N 0.000 description 2
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 229940096919 glycogen Drugs 0.000 description 2
- 230000002440 hepatic effect Effects 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 229960004488 linolenic acid Drugs 0.000 description 2
- 230000037356 lipid metabolism Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000003716 rejuvenation Effects 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 2
- 235000015500 sitosterol Nutrition 0.000 description 2
- 229950005143 sitosterol Drugs 0.000 description 2
- NLQLSVXGSXCXFE-UHFFFAOYSA-N sitosterol Natural products CC=C(/CCC(C)C1CC2C3=CCC4C(C)C(O)CCC4(C)C3CCC2(C)C1)C(C)C NLQLSVXGSXCXFE-UHFFFAOYSA-N 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 206010049865 Achromotrichia acquired Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 208000036487 Arthropathies Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 241000756943 Codonopsis Species 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 208000001380 Diabetic Ketoacidosis Diseases 0.000 description 1
- 208000007342 Diabetic Nephropathies Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 229940122069 Glycosidase inhibitor Drugs 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 102000003746 Insulin Receptor Human genes 0.000 description 1
- 108010001127 Insulin Receptor Proteins 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 208000012659 Joint disease Diseases 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 206010027336 Menstruation delayed Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- HZYXFRGVBOPPNZ-UHFFFAOYSA-N UNPD88870 Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)=CCC(CC)C(C)C)C1(C)CC2 HZYXFRGVBOPPNZ-UHFFFAOYSA-N 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000003288 anthiarrhythmic effect Effects 0.000 description 1
- 230000003178 anti-diabetic effect Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 208000033679 diabetic kidney disease Diseases 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 201000005577 familial hyperlipidemia Diseases 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 210000002683 foot Anatomy 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 229960001031 glucose Drugs 0.000 description 1
- 235000001727 glucose Nutrition 0.000 description 1
- 239000003316 glycosidase inhibitor Substances 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 230000002727 hyperosmolar Effects 0.000 description 1
- 230000000147 hypnotic effect Effects 0.000 description 1
- 208000006278 hypochromic anemia Diseases 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000004026 insulin derivative Substances 0.000 description 1
- 230000003914 insulin secretion Effects 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 201000005630 leukorrhea Diseases 0.000 description 1
- 230000004130 lipolysis Effects 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 238000013160 medical therapy Methods 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- -1 polysaccharide compound Chemical class 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 210000002325 somatostatin-secreting cell Anatomy 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 150000005856 steroid saponins Chemical class 0.000 description 1
- 230000003637 steroidlike Effects 0.000 description 1
- HCXVJBMSMIARIN-PHZDYDNGSA-N stigmasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]1(C)CC2 HCXVJBMSMIARIN-PHZDYDNGSA-N 0.000 description 1
- 229940032091 stigmasterol Drugs 0.000 description 1
- 235000016831 stigmasterol Nutrition 0.000 description 1
- BFDNMXAIBMJLBB-UHFFFAOYSA-N stigmasterol Natural products CCC(C=CC(C)C1CCCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C BFDNMXAIBMJLBB-UHFFFAOYSA-N 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 206010046901 vaginal discharge Diseases 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- DTOSIQBPPRVQHS-UHFFFAOYSA-N α-Linolenic acid Chemical compound CCC=CCC=CCC=CCCCCCCCC(O)=O DTOSIQBPPRVQHS-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/535—Perilla (beefsteak plant)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/62—Nymphaeaceae (Water-lily family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/82—Theaceae (Tea family), e.g. camellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8968—Ophiopogon (Lilyturf)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12G—WINE; PREPARATION THEREOF; ALCOHOLIC BEVERAGES; PREPARATION OF ALCOHOLIC BEVERAGES NOT PROVIDED FOR IN SUBCLASSES C12C OR C12H
- C12G3/00—Preparation of other alcoholic beverages
- C12G3/02—Preparation of other alcoholic beverages by fermentation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Insects & Arthropods (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公布了一种预防糖尿病的金花酒配方及其制备方法,包括以下质量份数的原料:高粱90~110份、小麦20~30份、茯砖茶8~12份、桑叶2~4份、甘草根1~3份、番石榴叶4~6份、紫苏籽3~5份、熟地黄4~6份、麦冬6~8份、苍术5~7份、莲藕10~12份、翻白草3~5份、黑翅土白蚁1~3份。本发明的目的是提供一种预防糖尿病的金花酒配方及其制备方法,长期适量饮用,可改善身体机能,提高免疫能力,能够对糖尿病起到早期预防和治疗的作用。
Description
技术领域
本发明涉及一种金花酒配方及其制备方法,尤其涉及一种预防糖尿病的金花酒配方及其制备方法。
背景技术
根据IDF统计,2015年全球糖尿病患者约有4.15亿人,每11个人就有1人患有糖尿病。预测到2040年,全球将会有6.42亿人患有糖尿病,中国糖尿病患者也将达到1.51亿。据国家卫计委和IDF统计,2012年我国18岁及以上成人糖尿病患病率为9.7%,2013年全球20岁~79岁成年人的糖尿病患病率为8.3%。
中国糖尿患者位居世界首位,趋于年轻化由于中国人口基数大,人口老龄化加剧以及饮食结构等因素,导致我国糖尿病患者人数约1.1亿人,位居世界第一,我国糖尿病消费群体量大。据IDF统计,2015年我国有130万人死于糖尿病及其并发症,其中40.8%的人年龄低于60岁,逐渐呈现年轻化趋势。
糖尿病如果控制的很好对人体影响不大。但如果控制不好,长期发展下去就会引起一系列的并发症,如糖尿病酮症酸中毒、高渗性昏迷、心脑血管病变、糖尿病肾病、糖尿病足等。这些并发症轻则会给患者带来很大痛苦、不适和生活不便,重则导致残疾甚至死亡。糖尿病的并发症在早期是可逆的,经严格治疗后会逆转,一旦到晚期后就会成为不可逆转,所以早期预防、早期治疗十分重要。
发明内容
本发明的目的是针对以上问题,提供一种预防糖尿病的金花酒配方及其制备方法,长期适量饮用,可改善身体机能,提高免疫能力,能够对糖尿病起到早期预防和治疗的作用。
为实现以上目的,本发明采用的技术方案是:一种预防糖尿病的金花酒配方,包括以下质量份数的原料:高粱90~110份、小麦20~30份、茯砖茶8~12份、桑叶2~4份、甘草根1~3份、番石榴叶4~6份、紫苏籽3~5份、熟地黄4~6份、麦冬6~8份、苍术5~7份、莲藕10~12份、翻白草3~5份、黑翅土白蚁1~3份。
较佳情况下,一种预防糖尿病的金花酒配方,包括以下质量份数的原料:高粱90份、小麦20份、茯砖茶8份、桑叶2份、甘草根1份、番石榴叶4份、紫苏籽3份、熟地黄4份、麦冬6份、苍术5份、莲藕10份、翻白草3份、黑翅土白蚁1份。
较佳情况下,一种预防糖尿病的金花酒配方,包括以下质量份数的原料:高粱100份、小麦25份、茯砖茶10份、桑叶3份、甘草根2份、番石榴叶5份、紫苏籽4份、熟地黄5份、麦冬7份、苍术6份、莲藕11份、翻白草4份、黑翅土白蚁2份。
较佳情况下,一种预防糖尿病的金花酒配方,包括以下质量份数的原料:高粱110份、小麦30份、茯砖茶12份、桑叶4份、甘草根3份、番石榴叶6份、紫苏籽5份、熟地黄6份、麦冬8份、苍术7份、莲藕12份、翻白草5份、黑翅土白蚁3份。
一种黑茶金花保健酒的制备方法,其特征在于,包括以下步骤:
①按照规定的质量份数称取高粱、小麦、茯砖茶、桑叶、甘草根、番石榴叶、紫苏籽、熟地黄、麦冬、苍术、莲藕、翻白草和黑翅土白蚁;
②将莲藕洗净,放在榨汁机中榨成汁液,过滤,制得莲藕汁;
③将桑叶、甘草根、番石榴叶、紫苏籽、熟地黄、麦冬、苍术、黑翅土白蚁和翻白草分别洗净,烘干备用;
④将桑叶、甘草根、番石榴叶、紫苏籽、熟地黄、麦冬、苍术和翻白草放置在锅中,加入纯净水进行煎煮,纯净水的用量为上述中药材总重量的40~50倍,煎煮时水温控制在60~80℃之间,时间为150~200分钟;冷却,过滤药渣,制得浸泡药液;
⑤将高粱、小麦、茯砖茶、烘干后的黑翅土白蚁、莲藕汁和浸泡药液放入到发酵罐中,加入发酵罐中原料总重量的2~3倍纯净水,进行密封发酵,发酵时将环境温度设置在20~35℃,发酵时间为35~40天,制得发酵液;
⑥将发酵液放入蒸馏器中进行蒸馏收集,即得预防糖尿病的金花酒。
较佳情况下,所述步骤④中煎煮时水温控制在70℃之间,时间为180分钟。
较佳情况下,所述步骤⑤中发酵时将环境温度设置在28℃,发酵时间为38天。
根据中医理论对处方的论述如下:
茯砖茶含有大量的冠突散囊菌,俗称金花,它能有效地调节人体新陈代谢,具有较强的降脂、降压、调节糖类代谢的功效;茯砖茶中的茶多糖复合物可以有效保护和调节胰岛素细胞的进行分泌,提高了降血糖能力。
桑叶中含有丰富的糖苷酶抑制剂1-脱氧野尻霉素(DNJ)和桑叶多糖。桑叶DNJ通过对糖类分解酶活性的抑制,从而抑制小肠对双糖的吸收,降低食后血糖的高峰值。桑叶多糖促进β细胞分泌胰岛素,胰岛素可以促进细胞对糖的利用、肝糖原合成以及改善糖代谢,最终达到降血糖的效果。桑叶中含有的粗蛋白质、氨基酸也能刺激胰岛素的分泌,并作为体内胰岛素分泌和释放的调节因素,降低胰岛素分解的速度。
甘草是传统中医中的一种很重要的草本植物,其使用种类记载已久。数千年来,中国医疗家们使用甘草来治疗多种疾病,上至喉咙痛,下至溃疡,而且还被当做养心和补脾的滋补品。最近医学研究表面,甘草根具有一种抗糖尿病效应的物质天然,对糖尿病可以起到预防作用;另外,甘草酿制药酒可以改善酒的味道。
番石榴叶中含有丰富的微量元素有机铬,而大多数糖尿病人体内都有明显的缺铬现象。铬是人体必需的微量元素,在正常的糖代谢和脂肪代谢中具有重要的作用。经研究证实,补充铬有助于改善糖尿病人和糖耐量异常者的葡萄糖耐量,降低血糖、血脂,增强胰岛素的敏感性。茶中含有番石榴多酚,这一物质可以抑制分解糖的酶活化,从而抑制了血糖的上升,同时也防止了胰岛素的过度分泌。
紫苏籽是至今为止发现的a-亚麻酸含量最高的植物物种,a-亚麻酸是人们必须的营养素之一,对人体的健康有重要的意义;a-亚麻酸作为生长、细胞代谢及肌肉运动供能只是其功能的一部分,其更多是作为结构物质和代谢调控物质,发挥结构功能和调控功能。a-亚麻酸可促进胰岛素β—细胞分泌胰岛素及使胰岛素在血液中维持稳定,可降低靶细胞对胰岛素的抵抗,提高细胞膜上胰岛素受体的敏感度,减少胰岛素的拮抗性。患糖尿病时,肌体内的脂肪分解加速,脂类代谢紊乱引起血脂增高,导致血管硬化、高血脂症、脂肪肝和高血压等并发症。此外,脂肪过度分解,会产生酮体,如酮体超过机体的利用限度,大量在体内堆积,就会产生酮症酸中毒。α—亚麻酸在人体内可调节脂类代谢,抑制并发症,降低酸、酮中毒的机率。同时α—亚麻酸对人体各器官及神经系统的保护作用和增强作用对糖尿病人是大有裨益的。
熟地黄主治肝肾阴虚、腰膝酸软、骨蒸潮热、盗汗遗精、内热消渴、血虚萎黄、心悸怔忡、月经不调、眩晕耳鸣、须发早白等症。用熟地黄治疗糖尿病古已有之,古人称糖尿病为“消渴”;现代医学治疗胰腺丧失部分和全部功能的病人一般使用降糖药物和胰岛素,而一旦使用胰岛素,则胰腺如果还有功能的话,也会很快完全丧失。所以,早期糖尿病患者最好是激发胰腺原有的功能,提高自身将血糖,血脂的能力,这才是早期防治糖尿病的关键。
麦冬主要含沿阶草苷、甾体皂苷、生物碱、谷甾醇、葡萄糖、氨基酸、维生素等,具有抗疲劳、清除自由基、提高细胞免疫功能以及降血糖的作用。另外,麦冬有镇静、催眠、抗心肌缺血、抗心律失常、抗肿瘤等作用,尤其对增进老年人健康具有多方面功效。此外,麦冬还有促进胰岛细胞功能恢复、增加肝糖原、降低血糖的作用,是糖友处方中的常用品。麦冬可代茶饮。取适量麦冬,开水浸泡,每天多服几次,能有效缓解口干渴的症状。部分糖尿病患者气阴两虚,因此饮用麦冬水时,可搭配一点党参,更能起到补气的作用。
苍术具有燥湿健脾,祛风散寒,明目的功效;用于治疗湿阻中焦,脘腹胀满,泄泻,水肿,脚气痿蹙,风湿痹痛,风寒感冒,夜盲,眼目昏涩。促进脾之运化,调节糖代谢。
莲藕微甜而脆,可生食也可做菜,而且药用价值相当高,它的根根叶叶,花须果实,无不为宝,都可滋补入药。用莲藕制成粉,能消食止泻,开胃清热,滋补养性,预防内出血,是妇孺童妪、体弱多病者上好的流质食品和滋补佳珍。莲藕汁酿制药酒能够中和缓解酒中的药味,改善药酒的味道。
翻白草具有清热解毒、凉血止血,可治疗痢疾、腹泻、白带、疟疾、吐血、便血、外伤出血,赤痢腹痛、久痢不止、痔疮出血、痈肿疮毒等功效。经研究发现翻白草对胰岛β细胞具有显著的修复作用,可以降低血糖、胆固醇及甘油三酯的含量。
黑翅土白蚁分布在中国黄河、长江以南各省市地区。黑翅土白蚁内存在有抗病物质甾体,主要有胆甾醇及其衍生物、谷甾醇、豆甾醇等,而且有人认为,这些物质对癌细胞有抑制作用。同时白蚁脂肪中所含的油酸、棕榈酸和硬脂酸等,也同样具有抑制肿瘤生长的作用。经研究发现白蚁体内的性诱激素和干扰素等,对胰岛细胞中的β细胞、α细胞、δ细胞、胰岛PP细胞均有显著的修复作用;对早期糖尿病的防治,具有非常重要的作用。
本发明的有益效果:
1.本发明提供的一种预防糖尿病的金花酒配方,其组方合理,诸味中药按照中医药理论配伍组合,集胰岛细胞修复、健脾胃、降血糖、血脂于一体,互补互利,相互作用,进一步调和及改善各方之功效,对风湿、关节病以及高血压具有良好的治疗效果。
2.本发明提供的一种预防糖尿病的金花酒,采用多种采药酿制,无任何化学成分添加,安全无毒副作用,能够对早期的糖尿病的治疗达到标本兼治的目的;且组分来源广泛,成本低廉;具有较高的临床应用价值和市场推广价值。
3.本发明提供的一种预防糖尿病的金花酒的制备方法,该方法简单易操作,药物煎煮后进行发酵更加均匀,使各组分之间的药用价值协同作用发挥更加显著,从而显著提高了金花酒的药用价值。
4.本发明提供的一种预防糖尿病的金花酒,不宜过多饮用,每日三次,每次饮用30-60ml,对于糖尿病的防治效果更佳。
具体实施方式
以下通过实施例进一步对本发明做出阐释。
实施例1:
一种预防糖尿病的金花酒配方,包括以下质量份数的原料:高粱90份、小麦20份、茯砖茶8份、桑叶2份、甘草根1份、番石榴叶4份、紫苏籽3份、熟地黄4份、麦冬6份、苍术5份、莲藕10份、翻白草3份、黑翅土白蚁1份。
一种黑茶金花保健酒的制备方法,其特征在于,包括以下步骤:
①按照规定的质量份数称取高粱、小麦、茯砖茶、桑叶、甘草根、番石榴叶、紫苏籽、熟地黄、麦冬、苍术、莲藕、翻白草和黑翅土白蚁;
②将莲藕洗净,放在榨汁机中榨成汁液,过滤,制得莲藕汁;
③将桑叶、甘草根、番石榴叶、紫苏籽、熟地黄、麦冬、苍术、黑翅土白蚁和翻白草分别洗净,烘干备用;
④将桑叶、甘草根、番石榴叶、紫苏籽、熟地黄、麦冬、苍术和翻白草放置在锅中,加入纯净水进行煎煮,纯净水的用量为上述中药材总重量的40~50倍,煎煮时水温控制在60,时间为150分钟;冷却,过滤药渣,制得浸泡药液;
⑤将高粱、小麦、茯砖茶、烘干后的黑翅土白蚁、莲藕汁和浸泡药液放入到发酵罐中,加入发酵罐中原料总重量的2倍纯净水,进行密封发酵,发酵时将环境温度设置在20℃,发酵时间为35天,制得发酵液;
⑥将发酵液放入蒸馏器中进行蒸馏收集,即得预防糖尿病的金花酒。
实施例2:
一种预防糖尿病的金花酒配方,包括以下质量份数的原料:高粱100份、小麦25份、茯砖茶10份、桑叶3份、甘草根2份、番石榴叶5份、紫苏籽4份、熟地黄5份、麦冬7份、苍术6份、莲藕11份、翻白草4份、黑翅土白蚁2份。
一种黑茶金花保健酒的制备方法,其特征在于,包括以下步骤:
①按照规定的质量份数称取高粱、小麦、茯砖茶、桑叶、甘草根、番石榴叶、紫苏籽、熟地黄、麦冬、苍术、莲藕、翻白草和黑翅土白蚁;
②将莲藕洗净,放在榨汁机中榨成汁液,过滤,制得莲藕汁;
③将桑叶、甘草根、番石榴叶、紫苏籽、熟地黄、麦冬、苍术、黑翅土白蚁和翻白草分别洗净,烘干备用;
④将桑叶、甘草根、番石榴叶、紫苏籽、熟地黄、麦冬、苍术和翻白草放置在锅中,加入纯净水进行煎煮,纯净水的用量为上述中药材总重量的45倍,煎煮时水温控制在70℃,时间为180分钟;冷却,过滤药渣,制得浸泡药液;
⑤将高粱、小麦、茯砖茶、烘干后的黑翅土白蚁、莲藕汁和浸泡药液放入到发酵罐中,加入发酵罐中原料总重量的3倍纯净水,进行密封发酵,发酵时将环境温度设置在28℃,发酵时间为38天,制得发酵液;
⑥将发酵液放入蒸馏器中进行蒸馏收集,即得预防糖尿病的金花酒。
实施例3:
一种预防糖尿病的金花酒配方,包括以下质量份数的原料:高粱110份、小麦30份、茯砖茶12份、桑叶4份、甘草根3份、番石榴叶6份、紫苏籽5份、熟地黄6份、麦冬8份、苍术7份、莲藕12份、翻白草5份、黑翅土白蚁3份。
一种黑茶金花保健酒的制备方法,其特征在于,包括以下步骤:
①按照规定的质量份数称取高粱、小麦、茯砖茶、桑叶、甘草根、番石榴叶、紫苏籽、熟地黄、麦冬、苍术、莲藕、翻白草和黑翅土白蚁;
②将莲藕洗净,放在榨汁机中榨成汁液,过滤,制得莲藕汁;
③将桑叶、甘草根、番石榴叶、紫苏籽、熟地黄、麦冬、苍术、黑翅土白蚁和翻白草分别洗净,烘干备用;
④将桑叶、甘草根、番石榴叶、紫苏籽、熟地黄、麦冬、苍术和翻白草放置在锅中,加入纯净水进行煎煮,纯净水的用量为上述中药材总重量的50倍,煎煮时水温控制在80℃之间,时间为200分钟;冷却,过滤药渣,制得浸泡药液;
⑤将高粱、小麦、茯砖茶、烘干后的黑翅土白蚁、莲藕汁和浸泡药液放入到发酵罐中,加入发酵罐中原料总重量的3倍纯净水,进行密封发酵,发酵时将环境温度设置在35℃,发酵时间为40天,制得发酵液;
⑥将发酵液放入蒸馏器中进行蒸馏收集,即得预防糖尿病的金花酒。
需要说明的是,在本文中,术语“包括”、“包含”或者其任何其他变体意在涵盖非排他性的包含,从而使得包括一系列要素的过程、方法、物品或者设备不仅包括哪些要素,而且还包括没有明确列出的其他要素,或者是还包括为这种过程、方法、物品或者设备所固有的要素。
以上对本发明所提供的一种预防糖尿病的金花酒配方及其制备方法进行了详细介绍,本文中对本发明的原理及实施方式进行了阐述,以上实施例的说明只是用于帮助理解本发明的方法及其核心思想;同时,对于本领域的一般技术人员,依据本发明的思想,在具体实施方式及应用范围上均会有改变之处,综上所述,本说明书内容不应理解为对本发明的限制。
Claims (7)
1.一种预防糖尿病的金花酒配方,其特征在于,包括以下质量份数的原料:高粱90~110份、小麦20~30份、茯砖茶8~12份、桑叶2~4份、甘草根1~3份、番石榴叶4~6份、紫苏籽3~5份、熟地黄4~6份、麦冬6~8份、苍术5~7份、莲藕10~12份、翻白草3~5份、黑翅土白蚁1~3份。
2.根据权利要求1所述的一种预防糖尿病的金花酒配方,其特征在于,包括以下质量份数的原料:高粱90份、小麦20份、茯砖茶8份、桑叶2份、甘草根1份、番石榴叶4份、紫苏籽3份、熟地黄4份、麦冬6份、苍术5份、莲藕10份、翻白草3份、黑翅土白蚁1份。
3.根据权利要求1所述的一种预防糖尿病的金花酒配方,其特征在于,包括以下质量份数的原料:高粱100份、小麦25份、茯砖茶10份、桑叶3份、甘草根2份、番石榴叶5份、紫苏籽4份、熟地黄5份、麦冬7份、苍术6份、莲藕11份、翻白草4份、黑翅土白蚁2份。
4.根据权利要求1所述的一种预防糖尿病的金花酒配方,其特征在于,包括以下质量份数的原料:高粱110份、小麦30份、茯砖茶12份、桑叶4份、甘草根3份、番石榴叶6份、紫苏籽5份、熟地黄6份、麦冬8份、苍术7份、莲藕12份、翻白草5份、黑翅土白蚁3份。
5.根据权利要求1-4中任意一项所述的一种黑茶金花保健酒的制备方法,其特征在于,包括以下步骤:
①按照规定的质量份数称取高粱、小麦、茯砖茶、桑叶、甘草根、番石榴叶、紫苏籽、熟地黄、麦冬、苍术、莲藕、翻白草和黑翅土白蚁;
②将莲藕洗净,放在榨汁机中榨成汁液,过滤,制得莲藕汁;
③将桑叶、甘草根、番石榴叶、紫苏籽、熟地黄、麦冬、苍术、黑翅土白蚁和翻白草分别洗净,烘干备用;
④将桑叶、甘草根、番石榴叶、紫苏籽、熟地黄、麦冬、苍术和翻白草放置在锅中,加入纯净水进行煎煮,纯净水的用量为上述中药材总重量的40~50倍,煎煮时水温控制在60~80℃之间,时间为150~200分钟;冷却,过滤药渣,制得浸泡药液;
⑤将高粱、小麦、茯砖茶、烘干后的黑翅土白蚁、莲藕汁和浸泡药液放入到发酵罐中,加入发酵罐中原料总重量的2~3倍纯净水,进行密封发酵,发酵时将环境温度设置在20~35℃,发酵时间为35~40天,制得发酵液;
⑥将发酵液放入蒸馏器中进行蒸馏收集,即得预防糖尿病的金花酒。
6.根据权利要求5所述的一种黑茶金花保健酒的制备方法,其特征在于,所述步骤④中煎煮时水温控制在70℃之间,时间为180分钟。
7.根据权利要求5所述的一种黑茶金花保健酒的制备方法,其特征在于,所述步骤⑤中发酵时将环境温度设置在28℃,发酵时间为38天。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710036270.1A CN106692760A (zh) | 2017-01-17 | 2017-01-17 | 一种预防糖尿病的金花酒配方及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710036270.1A CN106692760A (zh) | 2017-01-17 | 2017-01-17 | 一种预防糖尿病的金花酒配方及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106692760A true CN106692760A (zh) | 2017-05-24 |
Family
ID=58907699
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710036270.1A Pending CN106692760A (zh) | 2017-01-17 | 2017-01-17 | 一种预防糖尿病的金花酒配方及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106692760A (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109136023A (zh) * | 2018-08-02 | 2019-01-04 | 山西省农业科学院生物技术研究中心 | 一种保护心脏的白酒及制备方法 |
CN111642665A (zh) * | 2020-06-01 | 2020-09-11 | 顾亚祥 | 一种唤醒α细胞和β细胞的固体饮料及其制备方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105838538A (zh) * | 2016-04-18 | 2016-08-10 | 刘建良 | 一种黑茶金花保健酒配方及其制备方法 |
CN105963514A (zh) * | 2016-05-25 | 2016-09-28 | 邓院子 | 一种治疗糖尿病的中药制品及制备方法 |
-
2017
- 2017-01-17 CN CN201710036270.1A patent/CN106692760A/zh active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105838538A (zh) * | 2016-04-18 | 2016-08-10 | 刘建良 | 一种黑茶金花保健酒配方及其制备方法 |
CN105963514A (zh) * | 2016-05-25 | 2016-09-28 | 邓院子 | 一种治疗糖尿病的中药制品及制备方法 |
Non-Patent Citations (2)
Title |
---|
李乐愚: "《糖尿病的中西医治疗》", 30 November 2015, 中国中医药出版社 * |
茗溪: "《中国名茶品鉴速查全书》", 31 May 2014, 中国华侨出版社 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109136023A (zh) * | 2018-08-02 | 2019-01-04 | 山西省农业科学院生物技术研究中心 | 一种保护心脏的白酒及制备方法 |
CN111642665A (zh) * | 2020-06-01 | 2020-09-11 | 顾亚祥 | 一种唤醒α细胞和β细胞的固体饮料及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101695376B (zh) | 预防糖尿病的保健食品 | |
CN104435775B (zh) | 一种中药保健酒及其制备方法 | |
KR101090284B1 (ko) | 홍삼과 녹용 추출물을 포함하는 드링크제 및 그의 제조방법 | |
CN103099089A (zh) | 一种降糖、降压、通便减肥、抗疲劳、改善性功能保健品及其生产工艺 | |
CN102511867B (zh) | 红枣阿胶枸杞浓浆及其生产工艺 | |
CN102697047B (zh) | 一种枸杞口服液的制备方法 | |
CN101467582B (zh) | 九制益寿茶 | |
CN103027155A (zh) | 一种桑叶降脂降压保健茶及其制备方法 | |
CN105695258A (zh) | 一种含荔枝核皂苷的女性保健酒 | |
CN103719497A (zh) | 一种绞股蓝降脂减肥保健茶及其制备方法 | |
CN105454576A (zh) | 茉莉花八宝茶及其制备方法 | |
CN110051815A (zh) | 一种辅助降血糖食丸及其制备方法 | |
CN107751993A (zh) | 一种抗疲劳膏滋及其制备方法 | |
CN111110792A (zh) | 一种控糖调脂降粘防治糖尿病及其并发症的黄精人参茶 | |
CN103749824A (zh) | 一种绞股蓝降糖降压保健茶及其制备方法 | |
CN103719495A (zh) | 一种牛蒡子降糖降脂保健茶及其制备方法 | |
CN105685317A (zh) | 富含硒火麻茶及其制备方法 | |
CN106692760A (zh) | 一种预防糖尿病的金花酒配方及其制备方法 | |
CN104783174A (zh) | 一种纯天然营养免疫保健固体饮料的配制方法 | |
CN105077467A (zh) | 一种具有降血糖功效的鲍参保健饮料 | |
CN108186966A (zh) | 一种预防或改善老年痴呆症的组合物及其应用 | |
CN107712890A (zh) | 一种宁心安神膏滋及其制备方法 | |
CN106822660A (zh) | 一种治疗心脑血管疾病的中药制剂 | |
CN102293296B (zh) | 降压抗癌茶 | |
CN107372947B (zh) | 一种泡袋式降糖茶及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170524 |
|
RJ01 | Rejection of invention patent application after publication |